Dr. Justin Matthew Asquith, MD

Dr. Asquith practices at Aspirus Wausau Hospital in Wausau, Wisconsin, part of Aspirus.

Dr. Asquith's NPI, 1699031138, was assigned on April 10, 2012. Dr. Asquith holds Wisconsin license 73499-20.

Dr. Asquith's primary practice is Aspirus Wausau Hospital, at 333 Pine Ridge Blvd, Wausau, WI 54401 in Marathon County. The practice phone is (715) 847-2000.

Dr. Asquith's primary practice is Aspirus Wausau Hospital in Wausau, Wisconsin, part of Aspirus. Dr. Asquith is also affiliated with Aspirus Rhinelander Hospital. The medical group on file is Aspirus Medical Group. Dmand AI also links Dr. Asquith to 3 more hospitals, 5 medical groups, 3 group practices and clinics and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Asquith practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Asquith's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Asquith's licenses on file in 2 states: Wisconsin and Ohio.

CMS data shows 1,325 Medicare services from Dr. Asquith across 7 procedure codes in 2024, for 277 Medicare patients. Medicare paid $72,777 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Asquith in 2024. The largest group is 65 to 74, with 146 patients. 69% of them have high blood pressure, and 69% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Asquith's median patient age at 71, with 57% women.

In 2024, Dr. Asquith wrote 1,775 Medicare Part D claims for 254 patients. 77% of them were for generic drugs. CMS names the drug for 1,479 of them, across 40 drugs with 11 or more claims each, at $3,422,732 in total drug cost. In 2023, CMS named 1,232 claims across 33 drugs.

Dr. Asquith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Asquith as offering telehealth.

CMS Open Payments shows 12 general payments to Dr. Asquith from 6 drug and device companies from 2018 to 2025. Education make up the largest share, 54% of the total. Exelixis Inc. paid the most, $207.